The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cole Douglas G. since 2010.
This trader's CIK number is 1486373.
At the time of last reporting, Cole Douglas G. was the Director of Denali Therapeutics Inc.. (stock ticker symbol DNLI).
Also see all insider trading activities at Denali Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | AVEO | 0 | $0 | 182,393 | $3,139,140 | 0 | $0 |
| 2010 | AVEO | 0 | $0 | 267,607 | $3,892,465 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | DNLI | 0 | $0 | 0 | $0 | 3,253 | $0 |
1. Aveo Pharmaceuticals, Inc. (AVEO)
2. Denali Therapeutics Inc. (DNLI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-05-12 | AVEO | Sale | 16,119 | 17.30 | 278,907 |
| 2011-05-13 | AVEO | Sale | 81,389 | 17.75 | 1,444,817 |
| 2011-05-16 | AVEO | Sale | 52,492 | 17.98 | 943,648 |
| 2011-01-03 | AVEO | Sale | 6,400 | 14.53 | 92,992 |
| 2010-12-31 | AVEO | Sale | 19,493 | 14.56 | 283,740 |
| 2010-12-30 | AVEO | Sale | 6,500 | 14.62 | 95,036 |
| 2010-12-29 | AVEO | Sale | 14,112 | 14.50 | 204,581 |
| 2010-12-28 | AVEO | Sale | 9,735 | 14.62 | 142,354 |
| 2010-12-23 | AVEO | Sale | 4,765 | 14.60 | 69,573 |
| 2010-12-27 | AVEO | Sale | 9,196 | 14.53 | 133,636 |
| 2010-12-21 | AVEO | Sale | 14,800 | 14.29 | 211,462 |
| 2010-12-22 | AVEO | Sale | 17,500 | 14.68 | 256,917 |
| 2010-12-17 | AVEO | Sale | 11,549 | 14.07 | 162,471 |
| 2010-12-20 | AVEO | Sale | 20,500 | 14.11 | 289,296 |
| 2010-12-15 | AVEO | Sale | 7,400 | 14.14 | 104,628 |
| 2010-12-16 | AVEO | Sale | 11,507 | 14.21 | 163,525 |
| 2010-12-13 | AVEO | Sale | 10,600 | 14.54 | 154,124 |
| 2010-12-14 | AVEO | Sale | 10,900 | 14.06 | 153,243 |
| 2010-12-10 | AVEO | Sale | 9,100 | 14.47 | 131,695 |
| 2010-12-09 | AVEO | Sale | 8,400 | 14.39 | 120,909 |
| 2010-12-07 | AVEO | Sale | 6,294 | 14.93 | 93,982 |
| 2010-12-08 | AVEO | Sale | 27,400 | 14.93 | 409,082 |
| 2010-12-06 | AVEO | Sale | 14,501 | 14.92 | 216,398 |
| 2010-12-03 | AVEO | Sale | 20,898 | 14.90 | 311,442 |
| 2010-12-01 | AVEO | Sale | 10,900 | 15.02 | 163,728 |
| 2010-12-02 | AVEO | Sale | 27,550 | 14.50 | 399,419 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-01 | DNLI | Option Ex | 3,253 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cole Douglas G. (Director of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.